Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.39 USD
Change Today -1.70 / -18.75%
Volume 2.2M
ARIA On Other Exchanges
As of 9:33 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin J. Duvall

Chief Commercial Officer and Executive Vice President,Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Mr. Martin J. Duvall, also known as Marty has been Chief Commercial Officer and Executive Vice President at Ariad Pharmaceuticals Inc. December 2013 since and served as its Senior Vice President of Commercial Operations since September 2011 to December 2013. Mr. Duvall served as Senior Vice President of Global Marketing & International Commercial Operations at Abraxis BioScience, Inc. since May 2009. Mr. Duvall served as Senior Vice President of Commercial Strategy & ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.


Johns Hopkins University
University of Kansas
Muhlenberg College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$683,385

Stock Options*

Restricted Stock Awards$650,320
All Other Compensation$34,303
Exercisable Options106,417
Exercisable Options Value$22,575
Unexercisable Options86,583
Unexercisable Options Value$67,725
Total Value of Options$90,300
Total Number of Options193,000

Total Compensation*

Total Annual Cash Compensation$717,688
Total Short Term Compensation$683,385
Other Long Term Compensation$684,623
Total Calculated Compensation$1,368,008
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $7.39 USD -1.70


Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at